Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type (Surgical, Non-surgical), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 72 Business Hours
Peri-implantitis Market Growth & Trends
The global peri-implantitis market size is expected to reach USD 1.3 billion by 2027, expanding at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%–98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.
The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.
Peri-implantitis Market Report Highlights
Peri-implantitis Market Growth & Trends
The global peri-implantitis market size is expected to reach USD 1.3 billion by 2027, expanding at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%–98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.
The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.
Peri-implantitis Market Report Highlights
- The surgical segment dominated the market in 2019 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
- Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
- Europe dominated the market in 2019 owing to the rising technological advancements for peri-implantitis treatment
- In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PERI-IMPLANTITIS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing Number Of Patients Having Dental Implants And A History Of Periodontitis
3.2.2.1 Advent Of Technological Advancements Pertaining To Dental Procedure
3.2.2.2 Rise In Behavioral Risk Factors Like Smoking And Diabetes
3.2.3 Market Restraint Analysis
3.2.3.1 High Cost Of Surgical Treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Peri-Implantitis: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 PESTEL Analysis
CHAPTER 4 PERI-IMPLANTITIS MARKET: METHOD TYPE SEGMENT ANALYSIS
4.1 Peri-Implantitis: Method Type Market Share Analysis, 2019 & 2027
4.2 Surgical
4.2.1 Surgical Method market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.2 Bone Regeneration
4.2.2.1 Bone Regeneration Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.3 Open Flap Debridement
4.2.3.1 Open Flap Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.4 Implantoplasty
4.2.4.1 Implantoplasty Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3 Non-Surgical
4.3.1 Non-Surgical Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.2 Mechanical Debridement
4.3.2.1 mechanical Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.3 Laser Debridement
4.3.3.1laser Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.4 Antibiotics
4.3.4.1 antibiotics Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.5 Others
4.3.5.1 others Market Estimates And Forecasts, 2016 - 2027 (USD Million)
CHAPTER 5 PERI-IMPLANTITIS MARKET: REGIONAL ANALYSIS
5.1 Peri-Implantitis: Regional Market Share Analysis, 2019 & 2027
5.2 North America
5.2.1 North America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3 Europe
5.3.1 Europe Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.4 France
5.3.4.1 France Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.2 China
5.4.2.1 China Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.3 India
5.4.3.1 India Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.4 Japan
5.4.4.1 Japan Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.5 South Korea
5.4.5.1 South Korea Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5 Latin America
5.5.1 Latin America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.4 Argentina
5.5.4.1 Argentina Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6 MEA
5.6.1 MEA Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.3 Saudi Arabia
5.6.3.1 Saudi Arabia Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.4 UAE
5.6.4.1 UAE Peri-Implantitis Market, 2016 - 2027 (USD Million)
CHAPTER 6 COMPANY PROFILES
6.1 Pfizer Inc.,
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic Initiatives
6.2 Cadila Pharmaceuticals
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic Initiatives
6.3 R.N. Laboratories Pvt. Ltd.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.4 Basic Pharma Life Science Pvt. Ltd
6.1.4.1Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Strategic Initiatives
6.5 Prachi Pharmaceuticals Private Limited
6.1.5.1Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Product Benchmarking
6.1.5.4 Strategic Initiatives
6.6 Geistlich Pharma Inc.
6.1.6.1Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Product Benchmarking
6.1.6.4 Strategic Initiatives
6.7 Healthy Life Pharma
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Product Benchmarking
6.1.7.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PERI-IMPLANTITIS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing Number Of Patients Having Dental Implants And A History Of Periodontitis
3.2.2.1 Advent Of Technological Advancements Pertaining To Dental Procedure
3.2.2.2 Rise In Behavioral Risk Factors Like Smoking And Diabetes
3.2.3 Market Restraint Analysis
3.2.3.1 High Cost Of Surgical Treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Peri-Implantitis: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 PESTEL Analysis
CHAPTER 4 PERI-IMPLANTITIS MARKET: METHOD TYPE SEGMENT ANALYSIS
4.1 Peri-Implantitis: Method Type Market Share Analysis, 2019 & 2027
4.2 Surgical
4.2.1 Surgical Method market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.2 Bone Regeneration
4.2.2.1 Bone Regeneration Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.3 Open Flap Debridement
4.2.3.1 Open Flap Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.4 Implantoplasty
4.2.4.1 Implantoplasty Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3 Non-Surgical
4.3.1 Non-Surgical Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.2 Mechanical Debridement
4.3.2.1 mechanical Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.3 Laser Debridement
4.3.3.1laser Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.4 Antibiotics
4.3.4.1 antibiotics Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.5 Others
4.3.5.1 others Market Estimates And Forecasts, 2016 - 2027 (USD Million)
CHAPTER 5 PERI-IMPLANTITIS MARKET: REGIONAL ANALYSIS
5.1 Peri-Implantitis: Regional Market Share Analysis, 2019 & 2027
5.2 North America
5.2.1 North America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3 Europe
5.3.1 Europe Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.4 France
5.3.4.1 France Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.2 China
5.4.2.1 China Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.3 India
5.4.3.1 India Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.4 Japan
5.4.4.1 Japan Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.5 South Korea
5.4.5.1 South Korea Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5 Latin America
5.5.1 Latin America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.4 Argentina
5.5.4.1 Argentina Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6 MEA
5.6.1 MEA Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.3 Saudi Arabia
5.6.3.1 Saudi Arabia Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.4 UAE
5.6.4.1 UAE Peri-Implantitis Market, 2016 - 2027 (USD Million)
CHAPTER 6 COMPANY PROFILES
6.1 Pfizer Inc.,
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic Initiatives
6.2 Cadila Pharmaceuticals
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic Initiatives
6.3 R.N. Laboratories Pvt. Ltd.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.4 Basic Pharma Life Science Pvt. Ltd
6.1.4.1Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Strategic Initiatives
6.5 Prachi Pharmaceuticals Private Limited
6.1.5.1Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Product Benchmarking
6.1.5.4 Strategic Initiatives
6.6 Geistlich Pharma Inc.
6.1.6.1Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Product Benchmarking
6.1.6.4 Strategic Initiatives
6.7 Healthy Life Pharma
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Product Benchmarking
6.1.7.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 1 List of secondary sources
Table 2 List of Abbreviation
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Peri-implantitis market snapshot (2019)
Fig. 10 Peri-implantitis market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Peri-implantitis market method type outlook: Segment dashboard
Fig. 17 Peri-implantitis market: Product movement analysis
Fig. 18 Surgical market 2016 - 2027 (USD Million)
Fig. 19 Bone Regeneration market, 2016 - 2027 (USD Million)
Fig. 20 Open Flap Debridement market, 2016 - 2027 (USD Million)
Fig. 21 Implantoplasty market, 2016 - 2027 (USD Million)
Fig. 22 Non-surgical market, 2016 - 2027 (USD Million)
Fig. 23 Mechanical Debridement market, 2016 - 2027 (USD Million)
Fig. 24 Laser Debridement market, 2016 - 2027 (USD Million)
Fig. 25 Antibiotics market, 2016 - 2027 (USD Million)
Fig. 26 Others market, 2016 - 2027 (USD Million)
Fig. 27 Regional market: Key takeaways
Fig. 28 Regional outlook, 2019 & 2027
Fig. 29 North America market, 2016 - 2027 (USD Million)
Fig. 30 U.S. market, 2016 - 2027 (USD Million)
Fig. 31 Canada market, 2016 - 2027 (USD Million)
Fig. 32 Europe market, 2016 - 2027 (USD Million)
Fig. 33 U.K. market, 2016 - 2027 (USD Million)
Fig. 34 Germany market, 2016 - 2027 (USD Million)
Fig. 35 France market, 2016 - 2027 (USD Million)
Fig. 36 Italy market, 2016 - 2027 (USD Million)
Fig. 37 Spain market, 2016 - 2027 (USD Million)
Fig. 38 Asia Pacific market, 2016 - 2027 (USD Million)
Fig. 39 China market, 2016 - 2027 (USD Million)
Fig. 40 India market, 2016 - 2027 (USD Million)
Fig. 41 Japan market, 2016 - 2027 (USD Million)
Fig. 42 South Korea market, 2016 - 2027 (USD Million
Fig. 43 Latin America market, 2016 - 2027 (USD Million)
Fig. 44 Brazil market, 2016 - 2027 (USD Million)
Fig. 45 Mexico market, 2016 - 2027 (USD Million)
Fig. 46 Argentina market, 2016 - 2027 (USD Million)
Fig. 47 MEA market, 2016 - 2027 (USD Million)
Fig. 48 South Africa market, 2016 - 2027 (USD Million)
Fig. 49 Saudi Arabia market, 2016 - 2027 (USD Million)
Fig. 50 MEA market, 2016 - 2027 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Peri-implantitis market snapshot (2019)
Fig. 10 Peri-implantitis market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Peri-implantitis market method type outlook: Segment dashboard
Fig. 17 Peri-implantitis market: Product movement analysis
Fig. 18 Surgical market 2016 - 2027 (USD Million)
Fig. 19 Bone Regeneration market, 2016 - 2027 (USD Million)
Fig. 20 Open Flap Debridement market, 2016 - 2027 (USD Million)
Fig. 21 Implantoplasty market, 2016 - 2027 (USD Million)
Fig. 22 Non-surgical market, 2016 - 2027 (USD Million)
Fig. 23 Mechanical Debridement market, 2016 - 2027 (USD Million)
Fig. 24 Laser Debridement market, 2016 - 2027 (USD Million)
Fig. 25 Antibiotics market, 2016 - 2027 (USD Million)
Fig. 26 Others market, 2016 - 2027 (USD Million)
Fig. 27 Regional market: Key takeaways
Fig. 28 Regional outlook, 2019 & 2027
Fig. 29 North America market, 2016 - 2027 (USD Million)
Fig. 30 U.S. market, 2016 - 2027 (USD Million)
Fig. 31 Canada market, 2016 - 2027 (USD Million)
Fig. 32 Europe market, 2016 - 2027 (USD Million)
Fig. 33 U.K. market, 2016 - 2027 (USD Million)
Fig. 34 Germany market, 2016 - 2027 (USD Million)
Fig. 35 France market, 2016 - 2027 (USD Million)
Fig. 36 Italy market, 2016 - 2027 (USD Million)
Fig. 37 Spain market, 2016 - 2027 (USD Million)
Fig. 38 Asia Pacific market, 2016 - 2027 (USD Million)
Fig. 39 China market, 2016 - 2027 (USD Million)
Fig. 40 India market, 2016 - 2027 (USD Million)
Fig. 41 Japan market, 2016 - 2027 (USD Million)
Fig. 42 South Korea market, 2016 - 2027 (USD Million
Fig. 43 Latin America market, 2016 - 2027 (USD Million)
Fig. 44 Brazil market, 2016 - 2027 (USD Million)
Fig. 45 Mexico market, 2016 - 2027 (USD Million)
Fig. 46 Argentina market, 2016 - 2027 (USD Million)
Fig. 47 MEA market, 2016 - 2027 (USD Million)
Fig. 48 South Africa market, 2016 - 2027 (USD Million)
Fig. 49 Saudi Arabia market, 2016 - 2027 (USD Million)
Fig. 50 MEA market, 2016 - 2027 (USD Million)
